Search results
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 5 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 20 hours agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News via Yahoo News· 2 days agoMissouri Sen. Josh Hawley is pushing to expand payments to those exposed to Manhattan Project...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 9 hours agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
20 30-Minute Mediterranean Diet Dinners for Spring
Eating Well via Yahoo News· 4 days agoShe created this recipe for Lemongrass-&-Coconut Poached Salmon exclusively for EatingWell. It features a trifecta of inflammation-fighting...
Joint Pain in Big Toe: Possible Causes and Treatment
Healthline· 5 days agoConsider the following possible causes of joint pain in your big toe, including symptoms, risk factors, and prevention strategies. A type of arthritis,...
VB man sentenced in major coupon fraud scheme denied early release
WAVY via Yahoo News· 1 day agoA Virginia Beach man sentenced for his involvement in his wife's $31 million-plus counterfeit coupon...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 4 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
VTYX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
WPRI Providence· 6 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
Zurcher Kantonalbank Zurich Cantonalbank Has $173.91 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoZurcher Kantonalbank Zurich Cantonalbank boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.5% during the 4th quarter, according to the company in its most recent Form ...